Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial
I Schwartz, ME Boesen, G Cerchiaro… - … Open Access Journal, 2021 - cmajopen.ca
Background: Identification of therapies to prevent severe COVID-19 remains a priority. We
sought to determine whether hydroxychloroquine treatment for outpatients with SARS-CoV-2 …
sought to determine whether hydroxychloroquine treatment for outpatients with SARS-CoV-2 …
Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial
Importance Data on the efficacy of hydroxychloroquine for the treatment of coronavirus
disease 2019 (COVID-19) are needed. Objective To determine whether hydroxychloroquine …
disease 2019 (COVID-19) are needed. Objective To determine whether hydroxychloroquine …
[HTML][HTML] Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE–Coalition V): A double-blind, multicentre, randomised …
Á Avezum, GBF Oliveira, H Oliveira… - The Lancet Regional …, 2022 - thelancet.com
Summary Background Previous Randomised controlled trials (RCT) evaluating chloroquine
and hydroxychloroquine in non-hospitalised COVID-19 patients have found no significant …
and hydroxychloroquine in non-hospitalised COVID-19 patients have found no significant …
[HTML][HTML] Effect of hydroxychloroquine in hospitalized patients with Covid-19
RECOVERY Collaborative Group - New England Journal of …, 2020 - Mass Medical Soc
Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
SM Lofgren, MR Nicol, AS Bangdiwala… - Open forum …, 2020 - academic.oup.com
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns …
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns …
Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital
O Paccoud, F Tubach, A Baptiste… - Clinical Infectious …, 2021 - academic.oup.com
Background Data from nonrandomized studies have suggested that hydroxychloroquine
could be an effective therapeutic agent against coronavirus disease 2019 (COVID-19) …
could be an effective therapeutic agent against coronavirus disease 2019 (COVID-19) …
Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID‐19). Conventional meta‐analyses cannot fully address …
coronavirus disease 2019 (COVID‐19). Conventional meta‐analyses cannot fully address …
[HTML][HTML] Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
Aim To assess the efficacy and safety of hydroxychloroquine with or without azithromycin) in
hospitalized adult patients with COVID-19. Methods We utilized a hospital based …
hospitalized adult patients with COVID-19. Methods We utilized a hospital based …
[HTML][HTML] Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study
Background Hydroxychloroquine has not been associated with improved survival among
hospitalized COVID-19 patients in the majority of observational studies and similarly was not …
hospitalized COVID-19 patients in the majority of observational studies and similarly was not …
[HTML][HTML] Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: a randomized controlled trial
C Hernandez-Cardenas, I Thirion-Romero… - PLoS …, 2021 - journals.plos.org
Introduction The novel coronavirus pandemic (COVID–19) represents a major public health
problem and it is key to find a treatment that reduces mortality. Our objective was to estimate …
problem and it is key to find a treatment that reduces mortality. Our objective was to estimate …
Related searches
- covid 19 safety of hydroxychloroquine
- covid 19 outpatient treatment
- outpatient treatment safety of hydroxychloroquine
- covid 19 hospitalized patients
- covid 19 trial participants
- covid 19 compassionate use
- covid 19 meta analysis
- trial participants safety of hydroxychloroquine
- covid 19 clinical status
- effect of hydroxychloroquine hospitalized patients
- hydroxychloroquine for treatment meta analysis
- clinical status hospitalized patients
- covid 19 hydroxychloroquine in the treatment
- covid 19 efficacy and safety
- covid 19 placebo in the treatment
- outpatient treatment efficacy and safety